Prolactinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no established risk factors for [[prolactinoma]]. | There are no established risk factors for [[prolactinoma]]. Some conditions increases the risk of [[prolactinoma]] such as [[Multiple endocrine neoplasia type 1]] ([[MEN 1]]),[[Carney complex]], [[McCune-Albright Syndrome]], Familial isolated pituitary adenoma and MEN-1 like syndrome. | ||
Some conditions increases the risk of [[prolactinoma]] such as [[Multiple endocrine neoplasia type 1]] ([[MEN 1]]),[[Carney complex]], [[McCune-Albright Syndrome]], Familial isolated pituitary adenoma and MEN-1 like syndrome. | |||
==Risk factors== | ==Risk factors== | ||
*There are no established risk factors for [[prolactinoma]]. Most commonly [[prolactinoma]] are sporadic. | *There are no established risk factors for [[prolactinoma]]. Most commonly [[prolactinoma]] are sporadic. | ||
Revision as of 20:37, 24 July 2017
|
Prolactinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prolactinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Prolactinoma risk factors |
|
Risk calculators and risk factors for Prolactinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There are no established risk factors for prolactinoma. Some conditions increases the risk of prolactinoma such as Multiple endocrine neoplasia type 1 (MEN 1),Carney complex, McCune-Albright Syndrome, Familial isolated pituitary adenoma and MEN-1 like syndrome.
Risk factors
- There are no established risk factors for prolactinoma. Most commonly prolactinoma are sporadic.
- Prolactinoma may occur as part of:[1][2]
- Multiple endocrine neoplasia type 1 (MEN 1)
- Carney complex
- McCune-Albright Syndrome
- Familial isolated pituitary adenoma
- MEN-1 like syndrome
References
- ↑ Karhu A, Aaltonen LA (2007). "Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update". Hum Mol Genet. 16 Spec No 1: R73–9. doi:10.1093/hmg/ddm036. PMID 17613551.
- ↑ Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.